Efficacy of Azelastine & Mometasone Irrigation in Comparison to Nasal

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to determine the best combination of drugs and drug delivery routes to treat surgically naive chronic rhinitis patients. The main question it aims to answer is: Do high volume, high pressure delivery mechanisms in nasal irrigation improve the efficacy of azelastine combined with nasal steroid mometasone as compared to the standard low pressure, low volume delivery mechanisms in nasal sprays? Subjects will complete six months of one of three medication regimens: 1. Saline irrigation followed by azelastine spray and mometasone spray 2. Mometasone saline irrigation 3. Azelastine saline irrigation combined with mometasone saline irrigation.

Clinical Trial Description

The purpose of this research is to determine whether patients with chronic rhinitis treated with mometasone and azelastine irrigations will show significant clinical improvement when compared to patients treated with mometasone and azelastine nasal sprays, and also compared to nasal irrigation with mometasone alone. Patients with chronic rhinitis require lifelong treatment options that are safe yet efficacious. Topical therapies, such as antihistamine sprays and steroid sprays as well as saline irrigations, are appropriate options as they offer symptom control without the side effects often seen in antibiotics. Azelastine and mometasone are FDA approved medications for the treatment of chronic rhinitis. Using these drugs in an off-label format in the form of irrigations rather than sprays is standard of care in rhinology. Prior studies suggest irrigation may be better than spray for topical mometasone, but more data is needed to establish the same for the combination of mometasone and azelastine. Eligible patients who are enrolled in the study will be randomized and will complete six months of one of three medication regimens. Subjects will come back to the office for three follow up visits at 4, 12, and 24 weeks after the treatment, where they will have a basic nasal endoscopy performed and be asked to complete a questionnaire about their nasal blockage symptoms. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05626621
Study type	Interventional
Source	NorthShore University HealthSystem
Contact
Status	Recruiting
Phase	Phase 4
Start date	November 23, 2022
Completion date	August 2026

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT05331222` - Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis	N/A
Active, not recruiting	`NCT05591989` - Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)	N/A
Active, not recruiting	`NCT04614324` - A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)	N/A
Recruiting	`NCT01546662` - A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.	N/A
Terminated	`NCT00737906` - Surgical Reduction of the Inferior Turbinates for Nasal Obstruction	Phase 4
Completed	`NCT03727347` - Posterior Nasal Nerve (PNN) Rhinitis Study	N/A
Recruiting	`NCT06128200` - NEUROMARK Randomized Controlled Trial	N/A
Active, not recruiting	`NCT04154605` - ClariFix Rhinitis RCT	N/A
Completed	`NCT04684875` - Quality of Life Impact of Chronic Rhinitis Treatment With Aerin Medical Device
Completed	`NCT01364467` - The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study	Phase 2
Completed	`NCT03181594` - Evaluation of the ClariFix™ Cryotherapy Device in Subjects With Chronic Rhinitis	N/A
Completed	`NCT05324397` - Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)	N/A
Completed	`NCT03739216` - Registry of Subject Treated With ClariFix
Recruiting	`NCT05937308` - NEUROMARK Registry Study	N/A
Active, not recruiting	`NCT04533438` - RhinAer Procedure for Treatment of Chronic Rhinitis Study	N/A
Completed	`NCT04375293` - Characterisation of the Nasal Microbiome in Patients With N-ERD	N/A
Completed	`NCT03893227` - Prevalence of Nasal Hyperreactivity in Chronic Upper Airway Inflammation
Terminated	`NCT00584662` - Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-allergic Rhinitis in Subjects With Persistent Nasal Congestion	N/A
Recruiting	`NCT05648565` - Effects of Radiofrequency Ablation of Posterior Nasal Nerves on Inflammatory Cytokines, Peak Nasal Inspiratory Flow, and Nasal Blood Flow in Patients With Chronic Rhinitis	N/A
Completed	`NCT04769596` - Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms